ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 266

Diagnostic Delays and Disparities in Access to Care in Systemic Lupus Erythematosus

Lisa Gaynon1, Nancy Liu2, Laura Trupin3, Jing Li4, Ishita Aggarwal3, Patricia Katz3, Maria Dall'Era5, Lindsey A. Criswell3, Cristina Lanata6, Louise Murphy7 and Jinoos Yazdany5, 1Internal Medicine, California Pacific Medical Center, San Francisco, CA, 2Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 3University of California San Francisco, San Francisco, CA, 4Medicine, UC San Francisco, San Francisco, CA, 5University of California, San Francisco, San Francisco, CA, 6Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 7Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Access to care and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Healthcare Disparities in Rheumatology Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) presents heterogeneously and can be difficult to diagnose. Once diagnosed, prompt evaluation and treatment by a specialist can prevent morbidity. Few studies have systematically quantified delays in diagnosis and access to specialty care in SLE. Using a large cohort of individuals with confirmed SLE, we aimed to characterize patient-perceived delays in diagnosis and access to specialty care at SLE onset.

Methods: Data were derived from the California Lupus Epidemiology Study (CLUES), a population-based, longitudinal, multi-ethnic cohort of patients with SLE. Data were collected via annual telephone interviews and in-person clinical visits. Questions included time from onset of symptoms to seeing a doctor and to diagnosis of SLE, the number of doctors seen before SLE diagnosis, specialty of diagnosing physician, specialty of doctor giving incorrect diagnosis, and the time until first visit with a specialist (rheumatologist or nephrologist) if not initially diagnosed by one. We examined the relationships between these variables and race/ethnicity, poverty (<125% of federal poverty level; FPL), education (≤high school, vocational/trade schooling, college, postgraduate), and self-assessed health literacy (adequate vs. limited, using a validated 4-item scale), testing the differences with chi-square tests.

Results: This study included 417 patients, 90% female with a mean age of 47±14 years. 90% met ≥4/11 ACR criteria for SLE; the balance had a physician diagnosis of SLE and/or lupus nephritis. The racial/ethnic distribution was 31% Caucasian, 35% Asian, 23% Hispanic and 11% African-American. Twenty-two percent had an education level ≤ high school, 19% were >125% FPL, and 40% with low health literacy. Time from symptom onset to seeing a doctor varied, with 65% seen in < 6 months, 12% in 6-12 months, 7% in 1-2 years and 16% waiting >2 years. Time from symptom onset to receiving a diagnosis also varied, with 48% of participants waiting >6 months. 39% of patients received an incorrect initial diagnosis, most commonly from primary care physicians. There were no significant differences for any of these outcomes by race, education, health literacy or poverty level. For patients who were initially diagnosed with SLE by a non-specialist, racial/ethnic minorities and those with a high school education or less were more likely to wait longer than 3 months for a referral (both p= 0.03). Compared with those with less education, patients with higher levels of education saw more doctors before receiving a correct diagnosis (mean=2.1 vs 2.6; p=0.02).

Conclusion: Overall approximately half of this study’s patients waited >6 months to receive a diagnosis of SLE, and 39% received an incorrect initial diagnosis. Access to specialty care varied significantly, with racial/ethnic minorities, and those with low education waiting longer to see a specialist. Those with a higher education level saw more doctors prior to receiving a diagnosis, which could potentially be explained by greater access to healthcare in general. This study suggests that efforts to decrease diagnostic delays and errors, particularly among at-risk populations with SLE, are warranted.


Disclosure: L. Gaynon, None; N. Liu, None; L. Trupin, None; J. Li, None; I. Aggarwal, None; P. Katz, None; M. Dall'Era, None; L. A. Criswell, None; C. Lanata, None; L. Murphy, None; J. Yazdany, None.

To cite this abstract in AMA style:

Gaynon L, Liu N, Trupin L, Li J, Aggarwal I, Katz P, Dall'Era M, Criswell LA, Lanata C, Murphy L, Yazdany J. Diagnostic Delays and Disparities in Access to Care in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/diagnostic-delays-and-disparities-in-access-to-care-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-delays-and-disparities-in-access-to-care-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology